Wantai Biological to cancel repurchased shares, reduce capital

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. will reduce its registered capital by canceling 729,970 repurchased shares. This decision, approved at the company's sixth board of directors meeting and sixth supervisory board meeting on October 15, 2025, and subsequently passed at the first extraordinary general meeting on October 31, 2025, changes the intended use of these shares from employee incentive programs to cancellation.

Following the cancellation, the company's total shares will decrease from 1,265,122,774 to 1,264,392,804, and the registered capital will similarly decrease from 1,265,122,774 yuan to 1,264,392,804 yuan. Creditors are invited to declare their claims between November 1, 2025, and December 15, 2025, either in person, by mail, or via email.

The extraordinary general meeting saw 618 shareholders and proxies attend, representing 989,569,982 shares, or 78.2644% of total voting shares. The special resolution for share cancellation passed with 99.9490% of A-share votes in favor, with all seven directors and three supervisors in attendance.